BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 119 filers reported holding BIOXCEL THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,094,149 | -73.1% | 432,470 | +98.4% | 0.00% | -75.0% |
| Q1 2023 | $4,067,712 | +508.9% | 217,991 | +285.9% | 0.01% | +500.0% |
| Q3 2022 | $668,000 | -63.9% | 56,493 | -59.7% | 0.00% | -66.7% |
| Q2 2022 | $1,852,000 | +11.4% | 140,278 | +76.5% | 0.01% | +20.0% |
| Q1 2022 | $1,662,000 | +148.8% | 79,474 | +141.9% | 0.01% | +400.0% |
| Q4 2021 | $668,000 | -57.0% | 32,852 | -35.9% | 0.00% | -66.7% |
| Q3 2021 | $1,555,000 | -59.1% | 51,221 | -60.9% | 0.00% | -66.7% |
| Q2 2021 | $3,806,000 | -40.9% | 130,957 | -12.3% | 0.01% | -47.1% |
| Q1 2021 | $6,445,000 | +763.9% | 149,326 | +768.2% | 0.02% | +466.7% |
| Q3 2020 | $746,000 | -79.3% | 17,200 | -74.7% | 0.00% | -83.3% |
| Q2 2020 | $3,605,000 | – | 68,002 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |